Solventum (SOLV) Other Non-Current Assets (2023 - 2026)
Solventum (SOLV) posted Other Non-Current Assets of $848.0 million for Q1 2026, up 4.18% on a QoQ basis from $814.0 million in Q4 2025, and down 59.73% year-over-year from $2.1 billion in Q1 2025.
Solventum (SOLV) Other Non-Current Assets (2023 - 2026) Analysis & Trends
Solventum's Other Non-Current Assets history runs 4 years deep, the most recent figure standing at $848.0 million for Q1 2026.
- Quarterly Other Non-Current Assets fell 59.73% year-over-year to $848.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $848.0 million (down 59.73% YoY) and the FY2025 annual result came in at $814.0 million, up 22.41% from the prior year.
- Other Non-Current Assets was $848.0 million for Q1 2026 at Solventum, up from $814.0 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $2.1 billion in Q1 2025 and bottomed at $168.0 million in Q2 2025.
- A 4-year average of $751.7 million and a median of $624.0 million in 2024 frame the typical range for Other Non-Current Assets.
- Peak annual rise in Other Non-Current Assets reached 261.23% in 2025, while the deepest fall reached 66.86% in 2025.
- Solventum's Other Non-Current Assets stood at $530.0 million in 2023, then climbed by 25.47% to $665.0 million in 2024, then climbed by 22.41% to $814.0 million in 2025, then increased by 4.18% to $848.0 million in 2026.
- Business Quant data shows SOLV's Other Non-Current Assets at $848.0 million in Q1 2026, $814.0 million in Q4 2025, and $747.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 376.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 23.08 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 210.73 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 82.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 672.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 848.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 39.83 Mn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | 692.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 848.00 Mn |
| Dec 31, 2025 | 814.00 Mn |
| Sep 30, 2025 | 747.00 Mn |
| Jun 30, 2025 | 168.00 Mn |
| Mar 31, 2025 | 2.11 Bn |
| Dec 31, 2024 | 665.00 Mn |
| Sep 30, 2024 | 549.00 Mn |
| Jun 30, 2024 | 507.00 Mn |
| Mar 31, 2024 | 583.00 Mn |
| Dec 31, 2023 | 530.00 Mn |